Average Co-Inventor Count = 5.48
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (55 from 926 patents)
2. Virobay, Inc. (7 from 22 patents)
3. Gilead Pharmasset LLC (4 from 81 patents)
4. Axys Pharmaceuticals, Inc. (4 from 40 patents)
5. Aventis Pharmaceuticals Inc. (3 from 207 patents)
6. Amygdala Neurosciences, Inc. (2 from 4 patents)
7. Schering Aktiengesellschaft (1 from 1,384 patents)
8. University of Houston System (1 from 595 patents)
9. Gilead Scineces, Inc. (1 from 1 patent)
10. Quest Diagnostics Investments, Inc. (481 patents)
11. Carna Biosciences, Inc. (12 patents)
75 patents:
1. 12497382 - GLP-1R modulating compounds
2. 12404262 - Therapeutic compounds for HIV virus infection
3. 12338233 - PD-1/Pd-L1 inhibitors
4. 12269812 - PD-1/PD-L1 inhibitors
5. 11993583 - Therapeutic compounds
6. 11976072 - Diacylglycerol kinase modulating compounds
7. 11932634 - Diacylglycerol kinase modulating compounds
8. 11926628 - Diacylglyercol kinase modulating compounds
9. 11845723 - Diacylglycerol kinase modulating compounds
10. 11753399 - Therapeutic compounds
11. 11702404 - GLP-1R modulating compounds
12. 11555029 - PD-1/PD-L1 inhibitors
13. 11267801 - Therapeutic compounds
14. 11236085 - PD-1/PD-L1 inhibitors
15. RE48711 - Apoptosis signal-regulating kinase inhibitors